Amphastar Pharmaceuticals Inc (AMPH)

03:36 AM

Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - FinancialContent

03:36 AM

12:04 PM

What analysts say about Amphastar Pharmaceuticals Inc. stockAccelerated earnings growth - Autocar Professional

12:04 PM

12:00 PM

What Makes Amphastar (AMPH) a New Buy Stock - Yahoo Finance

12:00 PM

09:40 AM

Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock? - Yahoo.co

09:40 AM

09:35 AM

Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks - Yahoo.co

09:35 AM

06:05 AM

Is Amphastar Pharmaceuticals Inc. a good long term investmentFree Market Volatility Navigation Tips - jammulinksnews.com

06:05 AM

Jul 22, 2025

Amphastar Pharmaceuticals Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Hypoglycemia Pipeline 2025: Key Companies, MOA, ROA, - openPR.com

Jul 21, 2025

Jul 21, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month LowWhat's Next? - MarketBeat

Jul 21, 2025

Jul 21, 2025

Hussman Strategic Advisors Inc. Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Jul 21, 2025

Jul 20, 2025

What drives Amphastar Pharmaceuticals Inc. stock priceExceptional stock performance - printweek.in

Jul 20, 2025

Jul 19, 2025

Teacher Retirement System of Texas Lowers Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Jul 19, 2025

Jul 18, 2025

Amphastar Pharmaceuticals (AMPH) Plunges 4.98% on Strong Sell Rating - AInvest

Jul 18, 2025

Jul 18, 2025

agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know - Yahoo Finance

Jul 18, 2025

Jul 18, 2025

Amphastar Unveils Plans To Quadruple US Manufacturing - insights.citeline.com

Jul 18, 2025

Jul 17, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week LowHere's What Happened - MarketBeat

Jul 17, 2025

Jul 17, 2025

Principal Financial Group Inc. Purchases 4,669 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Jul 17, 2025

Jul 16, 2025

JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30 - MSN

Jul 16, 2025

Jul 16, 2025

Amphastar lays out plan to quadruple manufacturing capacity at its California HQ - Fierce Pharma

Jul 16, 2025

Jul 15, 2025

What makes Amphastar Pharmaceuticals Inc. stock price move sharplyFree Premium Stock Market Reports - Newser

Jul 15, 2025

Jul 15, 2025

Why Amphastar Pharmaceuticals Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 15, 2025

Jul 15, 2025

Amphastar to Quadruple Domestic Manufacturing - Association for Accessible Medicines

Jul 15, 2025

Jul 15, 2025

How Amphastar Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser

Jul 15, 2025

Jul 15, 2025

Amphastar stock hits 52-week low at $21.47 amid challenging year - Investing.com Canada

Jul 15, 2025

Jul 15, 2025

SteelPeak Wealth LLC Buys Shares of 55,795 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Jul 15, 2025

Jul 14, 2025

Amphastar to quadruple production capacity at California headquarters By Investing.com - Investing.com Nigeria

Jul 14, 2025

Jul 14, 2025

Amphastar to quadruple production capacity at California headquarters - Investing.com Australia

Jul 14, 2025

Jul 14, 2025

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters - ACCESS Newswire

Jul 14, 2025